Literature DB >> 12196119

X-ray crystallographic studies of IgG-Fc gamma receptor interactions.

P Sondermann1, V Oosthuizen.   

Abstract

Human Fc gamma receptors (Fc gamma Rs) for the Fc portion of IgG are major mediators of the adaptive immune response. Crystal structures of their extracellular domains were recently solved and shown to obey a common fold, resulting in a heart-shaped structure. Together with the multifunctional Fc fragment, whose structure was deciphered in the 1970s, the complex of an Fc gamma R with Fc was recently crystallized. Its crystal structure indicates that despite the dimeric character of the Fc fragment, only one Fc gamma R can bind to Fc, due to an introduced asymmetry within the homodimeric Fc, as well as by binding to symmetrically related residues of both Fc chains. Homology modelling suggested that the other Fc gamma Rs bind the Fc in a similar manner. The resolved complex structure can be regarded as a paradigm for Ig binding to Fc receptors and serves as a solid base for the design of compounds interfering with complex formation. Such molecules would be of invaluable benefit for the therapy of immunological disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196119     DOI: 10.1042/bst0300481

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  13 in total

1.  The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production.

Authors:  Paul Gallo; Ricardo Gonçalves; David M Mosser
Journal:  Immunol Lett       Date:  2010-07-27       Impact factor: 3.685

2.  Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats.

Authors:  Leslie A Khawli; Sirj Goswami; Ryan Hutchinson; Zephania W Kwong; Jihong Yang; Xiangdan Wang; Zhenling Yao; Alavattam Sreedhara; Tony Cano; Devin Tesar; Ihsan Nijem; David E Allison; Pin Yee Wong; Yung-Hsiang Kao; Cynthia Quan; Amita Joshi; Reed J Harris; Paul Motchnik
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

Review 3.  A perspective on the structure and receptor binding properties of immunoglobulin G Fc.

Authors:  Quinlin M Hanson; Adam W Barb
Journal:  Biochemistry       Date:  2015-05-07       Impact factor: 3.162

Review 4.  Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.

Authors:  P Mark Hogarth; Geoffrey A Pietersz
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

5.  The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G.

Authors:  Elizabeth R Sprague; Henrike Reinhard; Evelyn J Cheung; Alexander H Farley; Robin Deis Trujillo; Hartmut Hengel; Pamela J Bjorkman
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

Review 6.  The FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases.

Authors:  Peter Sondermann
Journal:  J Clin Immunol       Date:  2016-04-02       Impact factor: 8.317

Review 7.  CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity.

Authors:  Eugenia Corrales-Aguilar; Katja Hoffmann; Hartmut Hengel
Journal:  Semin Immunopathol       Date:  2014-10-07       Impact factor: 9.623

8.  Binding site on human immunoglobulin G for the affinity ligand HWRGWV.

Authors:  Haiou Yang; Patrick V Gurgel; D Keith Williams; Benjamin G Bobay; John Cavanagh; David C Muddiman; Ruben G Carbonell
Journal:  J Mol Recognit       Date:  2010 May-Jun       Impact factor: 2.137

9.  Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.

Authors:  Elizabeth R Sprague; Chu Wang; David Baker; Pamela J Bjorkman
Journal:  PLoS Biol       Date:  2006-05-02       Impact factor: 8.029

10.  Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III.

Authors:  Eugenia Corrales-Aguilar; Mirko Trilling; Katja Hunold; Manuela Fiedler; Vu Thuy Khanh Le; Henrike Reinhard; Katrin Ehrhardt; Eva Mercé-Maldonado; Enver Aliyev; Albert Zimmermann; David C Johnson; Hartmut Hengel
Journal:  PLoS Pathog       Date:  2014-05-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.